Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Accenture
Medtronic
Cerilliant
McKinsey
Moodys
Queensland Health
Colorcon
Baxter
Cipla

Generated: January 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 078274

« Back to Dashboard

NDA 078274 describes VECURONIUM BROMIDE, which is a drug marketed by Gland Pharma Ltd, Hospira, Mylan Labs Ltd, Sagent Pharms, Sun Pharma Global, Teva Pharms Usa, Watson Labs, and West-ward Pharms Int, and is included in ten NDAs. It is available from ten suppliers. Additional details are available on the VECURONIUM BROMIDE profile page.

The generic ingredient in VECURONIUM BROMIDE is vecuronium bromide. There are six drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the vecuronium bromide profile page.
Summary for 078274
Tradename:VECURONIUM BROMIDE
Applicant:Sagent Pharms
Ingredient:vecuronium bromide
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 078274
Medical Subject Heading (MeSH) Categories for 078274
Suppliers and Packaging for NDA: 078274
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
VECURONIUM BROMIDE vecuronium bromide INJECTABLE;INJECTION 078274 ANDA Sagent Pharmaceuticals 25021-657 25021-657-10 10 VIAL in 1 CARTON (25021-657-10) > 10 mL in 1 VIAL
VECURONIUM BROMIDE vecuronium bromide INJECTABLE;INJECTION 078274 ANDA Sagent Pharmaceuticals 25021-658 25021-658-20 10 VIAL in 1 CARTON (25021-658-20) > 20 mL in 1 VIAL

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength10MG/VIAL
Approval Date:Dec 29, 2008TE:APRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength20MG/VIAL
Approval Date:Dec 29, 2008TE:APRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Novartis
UBS
Farmers Insurance
Accenture
Federal Trade Commission
Baxter
Julphar
Colorcon
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot